Missouri Times: Patients Must Come First, Directly Benefit From Any 340B Drug Pricing Program Change

By Connie Farrow, Patients Come First Missouri Executive Director

The 340B Drug Pricing Program was intended to help our most vulnerable citizens access medicines and care when they are sick by providing steep discounts on outpatient drugs to qualifying healthcare entities that are supposed to pass the savings to patients.

There is growing concern that the federal program’s lack of oversight is allowing bad actors to turn around and charge patients higher prices and pocket the difference or use the profits to invest in unrelated programs. As they fund their own special interests, the most vulnerable patients are left unable to afford their medications. This is contrary to the program’s intended purpose.

Read the full text of the op-ed here.